AcelRx Pharmaceuticals (ACRX)

P/S ratio on March 13, 2024 (TTM) : 22.4

According to AcelRx Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.03. At the end of 2023 the company had a P/S ratio of 19.1.

P/S ratio history for AcelRx Pharmaceuticals from 2011 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	19.1	-71.35%
2022	66.8	181.65%
2021	23.7	14.51%
2020	20.7	-71.76%
2019	73.4	-13.28%
2018	84.6	563.38%
2017	12.7	87.75%
2016	6.79	-24.95%
2015	9.05	-83.95%
2014	56.4	241.67%
2013	16.5	-74.97%
2012	65.9	88.28%
2011	35.0

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Cara Therapeutics CARA	1.62	-92.78%	🇺🇸 USA
Recro Pharma REPH	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for AcelRx Pharmaceuticals (ACRX)

P/S ratio on March 13, 2024 (TTM) : 22.4